• Medicine
  • Published in
    Gan to kagaku ryoho. Cancer…
    2012

[Efficacy of combination therapy with EGFR-TKI and cytotoxic drug in lung adenocarcinoma already treated with EGFR-TKI].

@article{Hirano2012EfficacyOC,
  title={[Efficacy of combination therapy with EGFR-TKI and cytotoxic drug in lung adenocarcinoma already treated with EGFR-TKI].},
  author={Satoshi Hirano and Yuichiro Takeda and Yoshihisa Hiraishi and Mari Higashino and Shinji Nakamichi and Satoru Ishii and Go Naka and Motoyasu Iikura and Shinyu Izumi and Haruhito Sugiyama and Nobuyuki Kobayashi},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={2012},
  volume={39 2},
  pages={
          213-9
        }
}
UNLABELLED OBJECITVE: To assess the efficacy of combination therapy with EGFR-TKI and a cytotoxic drug in lung adenocarcinoma already being treated with EGFR-TKI. METHODS Eight patients with adenocarcinoma who were treated with combination therapy of EGFR-TKI and a cytotoxic drug between April 2008 and December 2010 were retrospectively evaluated for response rate, disease-control rate, progression-free survival(PFS), time-to-treatment-failure(TTF)and overall survival(OS). RESULTS Among the… CONTINUE READING